fashion -WSS

fashion

author：knowledge 2025-08-28 13:07:37 - browse：72

A masked person wears Onward Medical’s non-invasive spinal cord stimulator, solving a Rubik's cube — health tech coverage from STAT — Courtesy Onward Medical

After his spinal cord injury in 2014, Sherown Campbell worked hard to regain as much bodily function as he could. Once a dedicated athlete, Campbell had to learn the new limits of his body. One of them, jarringly, was his body’s inability to sweat.

So when Campbell started sweating on his stationary bike for the first time in seven years, it felt surreal. It was late 2021, and Campbell was nearing the end of a clinical trial testing out a device to help paralyzed patients regain movement.

“I felt really refreshed and excited, because you get to this point where normally I’d have to back off or monitor if I’m overheating,” Campbell, 41, said. “To break through that, it just feels clear.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

WSS

Gilead might be held responsible for not developing a drug

What do new weight loss drugs mean for bariatric surgery?

PhRMA lawsuit over Medicare drug price negotiation tossed

FDA panel gives mixed vote on blood pressure devices

Apellis safety probe of eye disease drug centers on injection needle

AstraZeneca challenges Medicare drug negotiation program

entertainment

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Virginia high school admissions case could be legal follow

AstraZeneca bets AAV gene therapy will still deliver the goods

The cancer drug shortage isn’t new — and neither are the solutions

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Bright Health sells Medicare Advantage business to Molina

NYU Langone launches private ChatGPT for its health care data

New air purifier tech could be key to improving indoor air quality

Radiation, mainstay of cancer treatment, begins a fade

FDA approval of Sarepta Duchenne genetic therapy gives me hope

AstraZeneca bets AAV gene therapy will still deliver the goods

focus

For Medicare Advantage, Democrats want stronger protections around AI

AstraZeneca bets AAV gene therapy will still deliver the goods

Robert F. Kennedy is pitching centrism on health, even on abortion

'Revelatory' study finds a smoking impact that remains after quitting

For Medicare Advantage, Democrats want stronger protections around AI

In science, is the line between industry and academia shifting?

explore

focus

focus

leisure time